A Phase 3, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A Inhalation Solution Delivered via the PARI Investigational eFLOW Device plus Standard of Care in the Treatme